Phreesia (PHR) Stock Forecast, Price & News

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PHR shares.
View PHR analyst ratings or view top-rated stocks.

13 brokers have issued 1 year price targets for Phreesia's shares. Their PHR share price forecasts range from $29.00 to $43.00. On average, they expect the company's share price to reach $37.15 in the next year. This suggests a possible upside of 109.2% from the stock's current price.
View analysts price targets for PHR or view top-rated stocks among Wall Street analysts.

Phreesia's stock was trading at $32.36 at the start of the year. Since then, PHR stock has decreased by 45.1% and is now trading at $17.76.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 14th 2023.
View our PHR earnings forecast.

Phreesia, Inc. (NYSE:PHR) announced its quarterly earnings results on Wednesday, September, 6th. The company reported ($0.68) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.71) by $0.03. The company earned $85.80 million during the quarter, compared to analyst estimates of $85.26 million. Phreesia had a negative trailing twelve-month return on equity of 54.52% and a negative net margin of 47.75%. The business's revenue for the quarter was up 26.4% on a year-over-year basis. During the same period last year, the company posted ($0.89) EPS.

ETFs with the largest weight of Phreesia (NYSE:PHR) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED) and iShares U.S. Healthcare Providers ETF (IHF) and

Phreesia issued an update on its FY 2025 earnings guidance on Wednesday, September, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$500.00 million, compared to the consensus revenue estimate of $453.67 million.

172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

(PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at a price of $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO.

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Phreesia's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.25%), Brown Advisory Inc. (6.02%), Jennison Associates LLC (4.79%), Credit Suisse AG (3.50%), Rock Springs Capital Management LP (2.43%) and Franklin Resources Inc. (2.35%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, Cheryl Pegus, David Linetsky, Edward L Cahill, Edward L Cahill, Evan Roberts, Gillian Munson, Janet Gunzburg, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, Randy Rasmussen and Thomas Altier.
View institutional ownership trends.

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PHR stock can currently be purchased for approximately $17.76.

Phreesia (NYSE:PHR) has a market capitalization of $980.53 million and generates $280.91 million in revenue each year. The company earns $-176,150,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis.

The company employs 1,546 workers across the globe.

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The official website for the company is www.phreesia.com. The company can be reached via phone at (888) 654-7473, via email at investors@phreesia.com, or via fax at 646-607-1776.